Liver Diseases  >>  capecitabine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

14 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
capecitabine / Generic mfg.
NCT00070265: Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer

Terminated
2
80
US
oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, capecitabine, CAPE, Ro 09-1978/000, Xeloda, therapeutic conventional surgery, laboratory biomarker analysis
National Cancer Institute (NCI)
Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
09/04
 
NCT00635323: Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

Completed
2
73
RoW
Irinotecan plus capecitabine
Pfizer
Carcinoma, Hepatocellular
 
05/05
SAKK 44/02, NCT00073905: Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Completed
2
44
Europe
capecitabine plus gemcitabine
Swiss Group for Clinical Cancer Research
Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer, Pain
06/06
01/09
NCT00351195 / 2005-003187-32: Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)

Terminated
2
39
Europe
Etoposide, Oxaliplatin, Capecitabine
Rigshospitalet, Denmark, Morten Ladekarl, MD, DMSc., Dept. of Oncology, Århus Sygehus, Århus
Hepatocellular Carcinoma
 
04/07
HCC-CAP, NCT00464295: Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)

Completed
2
15
RoW
Capecitabine in HCC
Aga Khan University
Carcinoma, Hepatocellular
 
10/07
NCT02013830: A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Completed
2
45
RoW
bevacizumab [Avastin], capecitabine [Xeloda]
Hoffmann-La Roche
Liver Cancer
03/08
03/08
NCT00483405: Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer

Checkmark P2 data
Nov 2011 - Nov 2011: P2 data
Completed
2
33
US
cetuximab, Erbitux, capecitabine, Xeloda, oxaliplatin, Eloxatin
UNC Lineberger Comprehensive Cancer Center, Sanofi, Roche Pharma AG, Bristol-Myers Squibb, National Center for Research Resources (NCRR), National Cancer Institute (NCI)
Liver Cancer
02/10
12/10
NCT00787787: Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Terminated
2
41
US
sunitinib malate, SU11248, sunitinib, Sutent, capecitabine, CAPE, Ro 09-1978/000, Xeloda
University of Washington, National Cancer Institute (NCI)
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
04/10
06/10
NCT01151761: Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation

Terminated
2
2
US
Stereotactic Body Radiotherapy, External photon radiation, Gemcitabine, Gemzar, Cisplatin, Platinol, Platinol-AQ, Carboplatin, Paraplatin, Paraplatin-AQ, Capecitabine, Xeloda, 5FU, Fluorouracil, Adrucil, Carac, Efudix, Efudex, Fluoroplex, Liver transplantation
Stanford University
Cholangiocarcinoma, Hepatobiliary Neoplasm, Liver Cancer, Bile Duct Cancer, Cancer of Gallbladder
04/12
07/12
NCT01320683: Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

Terminated
2
1
US
oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, leucovorin calcium, CF, CFR, LV, fluorouracil, 5-fluorouracil, 5-Fluracil, 5-FU, bevacizumab, anti-VEGF humanized monoclonal antibody, anti-VEGF monoclonal antibody, Avastin, rhuMAb VEGF, yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A, laboratory biomarker analysis, pharmacological study, pharmacological studies, irinotecan hydrochloride, Campto, Camptosar, CPT-11, irinotecan, U-101440E
City of Hope Medical Center, National Cancer Institute (NCI)
Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
12/14
12/14
PACOX, NCT02089633: Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC

Completed
2
17
RoW
PACOX, PEG-BCT-100, Xeloda, Eloxatin
Bio-Cancer Treatment International Limited, The University of Hong Kong
Hepatocellular Carcinoma
09/16
10/16
SWOG-S1310, NCT02042443: Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Completed
2
53
US
Capecitabine, Ro 09-1978/000, Xeloda, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Laboratory Biomarker Analysis, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Trametinib, GSK1120212, JTP-74057, MEK Inhibitor GSK1120212, Mekinist
National Cancer Institute (NCI)
Adult Cholangiocarcinoma, Advanced Adult Hepatocellular Carcinoma, BCLC Stage C Adult Hepatocellular Carcinoma, BCLC Stage D Adult Hepatocellular Carcinoma, Hilar Cholangiocarcinoma, Localized Non-Resectable Adult Liver Carcinoma, Recurrent Adult Liver Carcinoma, Recurrent Childhood Liver Cancer, Recurrent Extrahepatic Bile Duct Carcinoma, Recurrent Gallbladder Carcinoma, Stage II Gallbladder Cancer, Stage III Childhood Hepatocellular Carcinoma, Stage IIIA Gallbladder Cancer, Stage IIIB Gallbladder Cancer, Stage IV Childhood Hepatocellular Carcinoma, Stage IV Distal Bile Duct Cancer, Stage IVA Gallbladder Cancer, Stage IVB Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Carcinoma
01/17
04/17
NCT02015169: Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis

Completed
2
32
RoW
Lapatinib, Tykerb, GSK
Samsung Medical Center
HER2-positive Gastric Cancer Patients With Liver Metastasis
07/17
11/17
NCT00076609: Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Completed
1/2
31
US, RoW
PHY906, capecitabine
PhytoCeutica
Hepatocellular Carcinoma, Liver Cancer
 
 

Download Options